Avenue Therapeutics Inc. buy Aegis
Start price
03.04.23
/
50%
€1.09
Target price
03.04.24
€29.35
Performance (%)
-87.88%
End price
04.04.24
€0.13
Summary
This prediction ended on 04.04.24 with a price of €0.13. The BUY prediction by Aegis for Avenue Therapeutics Inc. performed very badly with a performance of -87.88%. Aegis has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Avenue Therapeutics Inc. | - | - | - |
iShares Core DAX® | -0.552% | 3.405% | 17.621% |
iShares Nasdaq 100 | -1.415% | 4.613% | 28.506% |
iShares Nikkei 225® | -0.877% | -1.396% | 9.284% |
iShares S&P 500 | -0.415% | 3.338% | 25.914% |
Comments by Aegis for this prediction
In the thread Avenue Therapeutics Inc. diskutieren
Avenue Therapeutics, Inc. (NASDAQ: ATXI) is now covered by analysts at Aegis. They set a "buy" rating and a $32.00 price target on the stock.
Ratings data for ATXI provided by MarketBeat
In the thread Trading Avenue Therapeutics Inc.
Die von Aegis gewählte maximale Laufzeit wurde überschritten